Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

Chiltern Launches “Chiltern Safe”, a Comprehensive Global Trial Master File Management Solution

November 15, 2010 Research and Development

“Chiltern SAFE is revolutionizing records management for clinical trials”, stated Sarah Hitching, Chiltern Director, Records Management. “This complete electronic Trial …
News
Press release

GSK partners with Brazil’s Fiocruz on tropical disease research

November 15, 2010 Research and Development Chagas disease, Fiocruz, GSK, GSK’s Tres Cantos Medicines Development Campus, GlaxoSmithKline, Oswald Cruz Foundation, leishmaniasis

GlaxoSmithKline and the Brazil-based Oswald Cruz Foundation (Fiocruz) are to research and develop new medicines for tropical diseases Chagas and …
News

Bavarian Nordic courting cancer vaccine backers

November 12, 2010 Research and Development, Sales and Marketing Bavarian Nordic, Dendreon, Prostvac, Provenge, TroVax, cancer vaccine, prostate cancer, prostate cancer vaccine, zibotentan

Danish biotech Bavarian Nordic is in ‘advanced discussions’ with a number of potential pharma partners for its phase II therapeutic …
News

FDA approves Merck’s HIV fat drug Egrifta

November 12, 2010 Research and Development, Sales and Marketing EMD Serono, Egrifta, FDA, HIV, Merck KGaA, abdominal fat in HIV, tesamorelin

US regulatory authorities have approved the first treatment indicated to target abdominal fat in patients with HIV after trials showed …
News
amanda_callaghan

ABPI appoints communications director

November 11, 2010 Research and Development, Sales and Marketing ABPI, Amanda Callaghan, Royal College of Nursing, appointment, research and development, sales and marketing

UK industry body the ABPI has appointed Amanda Callaghan director of corporate communications. She starts the role on 31 January …
Appointment

Pfizer enters drug repositioning collaboration with Biovista

November 11, 2010 Research and Development Biovista, FDA, Neurontin, Pfizer, Pfizer Indications Discovery Unit, drug repositioning, viagra

Pfizer has signed a pilot research agreement with drug repositioning specialist Biovista. The aim of the collaboration is to identify …
News

Patients in UK cancer trials quadruples

November 11, 2010 Research and Development Cancer Research UK, NCRI, National Cancer Research Institute, UK clinical research, cancer trials

The number of cancer patients in the UK participating in clinical studies has quadrupled in the last decade, according to …
News

Novartis drops late stage lung cancer candidate

November 11, 2010 Research and Development ASA404, Antisoma, NSCLC, Novartis, cancer research, lung cancer, non small cell lung cancer, non-small cell lung cancer

Novartis has discontinued phase III trials for its lung cancer candidate ASA404 after it once again failed to meet its …
News

Sanofi’s C diff vaccine fast tracked by FDA

November 10, 2010 Research and Development C diff, C diff vaccine, C difficile, Clostridium difficile, FDA, FDA fast-track, Sanofi, Sanofi Pasteur

A new vaccine aimed at preventing C difficile infections has been fast tracked by the FDA. The regulator’s decision signals …
News

Genzyme again snubs suitor Sanofi

November 10, 2010 Research and Development, Sales and Marketing Campath, Chris Viehbacher, Genzyme, Henri Termeer, Orphan Drugs, Plavix, Sanofi, Sanofi-Aventis, manufacturing compliance

Genzyme has once again snubbed Sanofi-Aventis as the French pharma firm continues its pursuit of the beleaguered biotech company. Henri …
News
Lilly headquarters

Lilly bolsters diagnostics presence with Avid acquisition

November 9, 2010 Research and Development Alzheimer's disease, Alzheimer’s disease, Avid Radiopharma, Eli Lilly, diabetes, emagacestat, florbetapir, lilly

Eli Lilly has acquired specialist diagnostics firm Avid Radiopharma in a deal that will bolster its diagnostics business. Philadelphia-based Avid …
News

Trial failure for Merck Serono’s Parkinson’s candidate

November 8, 2010 Research and Development Merck Serono, Newron Pharmaceuticals, Parkinson's disease, dopamine agonists, levodopa, safinamide

Merck Serono’s new alpha-aminoamide safinamide has failed to reach its primary endpoint in a study with Parkinson’s disease patients. Merck …
News

Roche’s melanoma candidate impresses in phase II trials

November 5, 2010 Research and Development BRAF protein, Cancer, Phase II, Plexxikon, RG7204, Roche

Roche’s mid-stage melanoma candidate has produced positive results in a difficult to treat cancer. RG7204 is an investigational, first-in-class molecule …
News

NicOx to halve HQ workforce

November 4, 2010 Research and Development, Sales and Marketing NicOx, job cuts, naproxcinod, pharma jobs

French pharmaceutical company NicOx is to halve the workforce at its Sophia Antipolis headquarters and is considering restructuring its Italian …
News

Biogen set to axe 650 jobs and focus on neurology

November 4, 2010 Research and Development, Sales and Marketing Biogen, Rituxan, job cuts, pharma jobs

Biogen Idec is set to cut hundreds of jobs and refocus its R&D in an effort to cut costs by …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026